- Small molecule drug development business Sareum Holdings said it had raised around £681k from a share issue.

The funds were raised at 0.4p per share and would be used to advance the company's lead internal TYK2/JAK1 inhibitor programmes towards human trials.

At 9:16am: [LON:SAR] Sareum Holdings PLC share price was -0.14p at 0.42p

Story provided by